Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
OnKure Therapeutics, Inc. (OKUR) had Weighted-Average Shares Outstanding (Diluted) of 13.42M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-15.93M |
|
-- |
|
-- |
|
$17.00M |
|
$-17.00M |
|
$1.07M |
|
$-15.93M |
|
$-15.93M |
|
$-15.93M |
|
$-15.93M |
|
$-15.93M |
|
$-15.93M |
|
$-17.00M |
|
$-16.79M |
|
13.42M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
13.42M |
$-1.19 |
|
$-1.19 |
|
| Balance Sheet Financials | |
$98.17M |
|
$0.93M |
|
$1.71M |
|
$99.88M |
|
$8.79M |
|
-- |
|
$0.45M |
|
$9.23M |
|
$90.65M |
|
$90.65M |
|
$90.65M |
|
13.44M |
|
| Cash Flow Statement Financials | |
$-14.01M |
|
$-0.02M |
|
$-0.08M |
|
$110.76M |
|
$96.66M |
|
$-14.10M |
|
$2.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.18 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.02M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-17.57% |
|
-17.57% |
|
-15.94% |
|
-17.57% |
|
$6.74 |
|
$-1.04 |
|
$-1.04 |
|